200 related articles for article (PubMed ID: 25608421)
1. [Improving insulin therapy in type 2 diabetes. Conquering barriers and assuring quality of life].
MMW Fortschr Med; 2014 Dec; 156(21-22):99. PubMed ID: 25608421
[No Abstract] [Full Text] [Related]
2. [Researchers illuminate diabetes therapy].
Pflege Z; 2014 Feb; 67(2):126. PubMed ID: 24730335
[No Abstract] [Full Text] [Related]
3. Learning from ORIGIN.
Bloomgarden ZT
J Diabetes; 2012 Sep; 4(3):191-2. PubMed ID: 22716648
[No Abstract] [Full Text] [Related]
4. Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.
Toyoda M; Kimura M; Yamamoto N; Miyauchi M; Umezono T; Suzuki D
J Nephrol; 2012; 25(6):989-95. PubMed ID: 22307438
[TBL] [Abstract][Full Text] [Related]
5. [Type 2 diabetes: early therapy intensification shows positive effects].
MMW Fortschr Med; 2012 Sep; 154(16):70-1. PubMed ID: 23045941
[No Abstract] [Full Text] [Related]
6. Starting insulin therapy in type 2 diabetes: lesson 1.
McCall AL
Curr Diab Rep; 2005 Oct; 5(5):325-6. PubMed ID: 16188164
[No Abstract] [Full Text] [Related]
7. ["Very good metabolic control by early insulin administration"].
Schumm-Draeger PM
MMW Fortschr Med; 2012 Jun; 154(12):25. PubMed ID: 22880291
[No Abstract] [Full Text] [Related]
8. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711
[No Abstract] [Full Text] [Related]
9. [Therapy with incretin mimetic exenatide. Soon HbA1c value and weight decrease permanently].
MMW Fortschr Med; 2006 Sep; 148(37):55. PubMed ID: 17036908
[No Abstract] [Full Text] [Related]
10. Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial.
Onishi Y; Ono Y; Rabøl R; Endahl L; Nakamura S
Diabetes Obes Metab; 2013 Sep; 15(9):826-32. PubMed ID: 23557077
[TBL] [Abstract][Full Text] [Related]
11. Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial.
Koivisto V; Cleall S; Pontiroli AE; Giugliano D
Diabetes Obes Metab; 2011 Dec; 13(12):1149-57. PubMed ID: 21819517
[TBL] [Abstract][Full Text] [Related]
12. [HbA1c is too high despite tablets. With single injections toward better blood glucose values].
MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347083
[No Abstract] [Full Text] [Related]
13. Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control.
Philis-Tsimikas A
Am J Med; 2013 Sep; 126(9 Suppl 1):S21-7. PubMed ID: 23953076
[TBL] [Abstract][Full Text] [Related]
14. Insulin glargine and educational intervention in patients with type 2 diabetes in clinical practice: long-term improvement in glycaemic control without weight gain.
Schreiber SA; Russmann A
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):41-2. PubMed ID: 16450317
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
Seufert J; Pegelow K; Bramlage P
Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
[TBL] [Abstract][Full Text] [Related]
16. [Insulin glargine. The most studied basal insulin].
Walter M
MMW Fortschr Med; 2013 Nov; 155(19):70-1. PubMed ID: 24475676
[No Abstract] [Full Text] [Related]
17. [Evaluation of the DIABOBHU Observational Study].
Gaál Z; Papp Z; Bakó B
Orv Hetil; 2014 Jun; 155(23):903-10. PubMed ID: 24880969
[TBL] [Abstract][Full Text] [Related]
18. [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].
Kress S
Dtsch Med Wochenschr; 2010 May; 135(18):907-10. PubMed ID: 20425675
[TBL] [Abstract][Full Text] [Related]
19. Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.
D'Alessio D; Häring HU; Charbonnel B; de Pablos-Velasco P; Candelas C; Dain MP; Vincent M; Pilorget V; Yki-Järvinen H;
Diabetes Obes Metab; 2015 Feb; 17(2):170-8. PubMed ID: 25359159
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin.
Dailey GE; Gao L; Aurand L; Garg SK
Diabetes Obes Metab; 2013 Dec; 15(12):1085-92. PubMed ID: 23683002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]